Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

Rare interstitial lung disease cases have been reported with albinterferon alfa-2b (albIFN) and pegylated interferon alfa-2a (Peg-IFNα-2a) in chronic hepatitis C virus (HCV) patients. Systematic pulmonary function evaluation was conducted in a study of albIFN q4wk vs Peg-IFNα-2a qwk in patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. R. Foster, S. Zeuzem, S. Pianko, S. K. Sarin, T. Piratvisuth, S. Shah, P. Andreone, A. Sood, W. L. Chuang, C. M. Lee, J. George, M. Gould, R. Flisiak, I. M. Jacobson, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, R. Sola, I. Messina, Y. Yin, S. Cammarata, G. Feutren, K. K. Brown
Format:	Journal
Published:	2018
Subjects:	Immunology and Microbiology Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875216158&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52647
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
by: G. R. Foster, et al.
Published: (2018)

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
by: Pianko S., et al.
Published: (2014)

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
by: S. Pianko, et al.
Published: (2018)

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
by: Pianko S., et al.
Published: (2014)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
by: Kao J., et al.
Published: (2017)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
by: Jia Horng Kao, et al.
Published: (2018)

Kombinasi interferon alfa-2b dengan ribavirin untuk terapi penderita hepatitis C kronik yang naive
by: Perpustakaan UGM, i-lib
Published: (2006)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
by: Lau G.K.K., et al.
Published: (2014)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
by: George K.K. Lau, et al.
Published: (2018)

Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2022)

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
by: Li, L., et al.
Published: (2011)

Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
by: Watcharasak Chotiyaputta, et al.
Published: (2019)

Inhibition of dengue virus replication by mycophenolic acid and ribavirin
by: Ratree Takhampunya, et al.
Published: (2018)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
by: Kumthip K., et al.
Published: (2017)

Failure of interferon alfa and tribavirin in rabies encephalitis
by: M. J. Warrell, et al.
Published: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
by: Seo, S., et al.
Published: (2016)

Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
by: Thidarath Rattanaburee, et al.
Published: (2018)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
by: Sachiko Seo, et al.
Published: (2018)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
by: Kattareeya Kumthip, et al.
Published: (2018)

Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
by: Low, EXS, et al.
Published: (2021)

Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?
by: Shilpa R. Jain, et al.
Published: (2020)

Activated drotrecogin alfa for treatment of severe sepsis in Singapore
by: Ping, C.A., et al.
Published: (2016)

Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection
by: Abel, Shawna, et al.
Published: (2022)

Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
by: K. Kumthip, et al.
Published: (2018)

Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
by: Kumthip K., et al.
Published: (2014)

Epoetin-alfa induced pruritic maculopapular eruption: Case report and literature review
by: Rueangsri R.
Published: (2023)

Mempelajari reaksi Alfa-Pineda dengan aqua-regia
by: , MASRURI, et al.
Published: (2001)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
by: Charatcharoenwitthaya P., et al.
Published: (2017)

Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy
by: Chusri,P., et al.
Published: (2015)

Antiviral mechanism of Nitric oxide, Mycophenolic acid and Ribavirin on dengue virus type 2 infection
by: Ratree Takhampunya
Published: (2023)

Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis
by: Manothummetha K.
Published: (2023)

PENGARUH PERENDAMAN CETAKAN ALGINAT DALAM LARUTAN KITOSAN OLIGOMER TERHADAP PERTUMBUHAN STREPTOCOCCUS ALFA
by: , Budi Santoso, et al.
Published: (2012)

Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis
by: Kalimuddin, S., et al.
Published: (2016)

Pengaruh pemberian Prostaglandin F2 Alfa (PGF2 Alfa) terhadap kualitas semen dan kadar testosteron domba lokal
by: , SAIFUDIN, Muhammad, et al.
Published: (2004)

Interleukin-28B Polymorphisms and Response of Chronic Hepatitis C Patients from Indonesia to Pegylated Interferon/Ribavirin Treatment
by: Juniastuti, et al.
Published: (2014)

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
by: Y. F. Liaw, et al.
Published: (2018)

Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore
by: Chan, A., et al.
Published: (2014)

Pengaruh kualitas pelayanan terhadap loyalitas konsumen pada Supermarket Alfa Yogyakarta
by: , WAHYUNI, Renny, et al.
Published: (2005)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
by: Satawat Thongsawat, et al.
Published: (2018)

Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
by: Satawat Thongsawat, et al.
Published: (2018)